These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
553 related articles for article (PubMed ID: 19604490)
1. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Colonna M Immunity; 2009 Jul; 31(1):15-23. PubMed ID: 19604490 [TBL] [Abstract][Full Text] [Related]
2. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871 [TBL] [Abstract][Full Text] [Related]
3. Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells. Satoh-Takayama N; Lesjean-Pottier S; Sawa S; Vosshenrich CA; Eberl G; Di Santo JP Eur J Immunol; 2011 Mar; 41(3):780-6. PubMed ID: 21341264 [TBL] [Abstract][Full Text] [Related]
4. Isolation of NK cells and NK-like cells from the intestinal lamina propria. Sanos SL; Diefenbach A Methods Mol Biol; 2010; 612():505-17. PubMed ID: 20033661 [TBL] [Abstract][Full Text] [Related]
5. STAT3 and its activators in intestinal defense and mucosal homeostasis. Hruz P; Dann SM; Eckmann L Curr Opin Gastroenterol; 2010 Mar; 26(2):109-15. PubMed ID: 20040863 [TBL] [Abstract][Full Text] [Related]
6. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Witte E; Witte K; Warszawska K; Sabat R; Wolk K Cytokine Growth Factor Rev; 2010 Oct; 21(5):365-79. PubMed ID: 20870448 [TBL] [Abstract][Full Text] [Related]
8. A 'natural' way to provide innate mucosal immunity. Di Santo JP; Vosshenrich CA; Satoh-Takayama N Curr Opin Immunol; 2010 Aug; 22(4):435-41. PubMed ID: 20573491 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Ciccia F; Accardo-Palumbo A; Alessandro R; Rizzo A; Principe S; Peralta S; Raiata F; Giardina A; De Leo G; Triolo G Arthritis Rheum; 2012 Jun; 64(6):1869-78. PubMed ID: 22213179 [TBL] [Abstract][Full Text] [Related]
10. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Ouyang W Cytokine Growth Factor Rev; 2010 Dec; 21(6):435-41. PubMed ID: 21106435 [TBL] [Abstract][Full Text] [Related]
11. Development and function of TH17 cells in health and disease. Louten J; Boniface K; de Waal Malefyt R J Allergy Clin Immunol; 2009 May; 123(5):1004-11. PubMed ID: 19410689 [TBL] [Abstract][Full Text] [Related]
12. Non-cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues. Münz C Eur J Immunol; 2008 Nov; 38(11):2946-8. PubMed ID: 18979517 [TBL] [Abstract][Full Text] [Related]
13. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Cella M; Fuchs A; Vermi W; Facchetti F; Otero K; Lennerz JK; Doherty JM; Mills JC; Colonna M Nature; 2009 Feb; 457(7230):722-5. PubMed ID: 18978771 [TBL] [Abstract][Full Text] [Related]
14. IL-22 producing NKp46+ innate lymphoid cells can differentiate from hematopoietic precursor cells. Kim MS; Kim WS; Piao ZH; Yun S; Lee SH; Lee S; Jeong M; Sun HN; Park YJ; Jung H; Yoon SR; Choi I Immunol Lett; 2011 Dec; 141(1):61-7. PubMed ID: 21835206 [TBL] [Abstract][Full Text] [Related]
15. Emergence of the Th17 pathway and its role in host defense. O'Quinn DB; Palmer MT; Lee YK; Weaver CT Adv Immunol; 2008; 99():115-63. PubMed ID: 19117534 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-21 signaling: functions in cancer and autoimmunity. Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166 [TBL] [Abstract][Full Text] [Related]
17. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Volpe E; Servant N; Zollinger R; Bogiatzi SI; Hupé P; Barillot E; Soumelis V Nat Immunol; 2008 Jun; 9(6):650-7. PubMed ID: 18454150 [TBL] [Abstract][Full Text] [Related]
18. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. Satoh-Takayama N; Lesjean-Pottier S; Vieira P; Sawa S; Eberl G; Vosshenrich CA; Di Santo JP J Exp Med; 2010 Feb; 207(2):273-80. PubMed ID: 20142427 [TBL] [Abstract][Full Text] [Related]
19. Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK. Mas AE; Petitbarat M; Dubanchet S; Fay S; Ledée N; Chaouat G Am J Reprod Immunol; 2008 Apr; 59(4):323-38. PubMed ID: 18336386 [TBL] [Abstract][Full Text] [Related]
20. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]